A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Glucocorticoid-remediable aldosteronism (GRA), an autosomal dominant disorder, is characterized by hypertension with variable hyperaldosteronism and by high levels of the abnormal adrenal steroids 18-oxocortisol and 18-hydroxycortisol, which are all under control of adrenocorticotropic hormone and suppressible by glucocorticoids. These abnormalities could result from ectopic expression of aldosterone synthase, which is normally expressed only in adrenal glomerulosa, in the adrenal fasciculata. Genes encoding aldosterone synthase and steroid 11 beta-hydroxylase (expressed in both adrenal fasciculata and glomerulosa), which are 95% identical and lie on chromosome 8q (refs 7, 10), are therefore candidate genes for GRA. Here we demonstrate complete linkage of GRA in a large kindred to a gene duplication arising from unequal crossing over, fusing the 5' regulatory region of 11 beta-hydroxylase to the coding sequences of aldosterone synthase (maximum lod score 5.23 for complete linkage, odds ratio of 170,000:1). This mutation can account for all the physiological abnormalities of GRA. Our result represents the demonstration of a mutation causing hypertension in otherwise phenotypically normal animals or humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with a tandem duplication event, the two human genes are closely linked, separated by 40 kb, exhibiting similar intron/exon structure, and 90 and 95% identity in the coding and non-coding sequences, respectively (59, 70).”
From Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies (2016) · cites this paper as [70]
In the citing paper
“Although gene conversion events in the CYP11B locus are rare, an unusual gene duplication, caused by unequal crossing over between the CYP11B1 and CYP11B2 genes, results in glucocorticoid-remediable aldosteronism (GRA) (490 -492).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [490]
In the citing paper
“The crossover results in one allele having a third, hybrid CYP11B gene in which the ACTHregulated promoter and the first few exons of CYP11B1 are fused in frame to most of the exons of CYP11B2, resulting in the zona fasciculata expression of a chimeric protein with aldosterone synthase activity (490, 491) (Fig. 12).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [490]
In the citing paper
“They are particularly important in patients in glucocorticoid remediable aldosteronism or with aldosterone-producing adenomas associated with KCNJ5 mutations [261,[264], [265], [266], [267], [268], [269], [270], [271], [272]].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [264]
In the citing paper
“Urinary excretion of aldosterone metabolites is increased (Fig. 6) (115, 124), with the urinary (18OHF+18oxoF)/THAldo ratio further supporting diagnosis (116); the urinary metabolite 18oxoTHF (Fig. 7) is characteristically increased.”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [124]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
Gilliland, G., Perrin, S., Blanchard, K., & Bunn, H. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2725 · Cited by 1,454
Hypertension: Pathophysiology, Diagnosis, and Management
White, W. B. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460110128039 · Cited by 944
Polymorphic DNA region adjacent to the 5' end of the human insulin gene.
Bell, G. I., Karam, J. H., & Rutter, W. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5759 · Cited by 889
Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH
Simpson, E. R., & Waterman, M. R. (1988) · Annual Review of Physiology · doi:10.1146/annurev.ph.50.030188.002235 · Cited by 506
Sutherland, D. J., Ruse, J. L., & Laidlaw, J. C. (1966) · PubMed Central · Cited by 467
Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta).
Mornet, É., Dupont, J., Vitek, A., & White, P. C. (1989) · PubMed · Cited by 440
Characterization of Two Genes Encoding Human Steroid 11β-Hydroxylase (P-45011β)
Mornet, E., Dupont, J., Vitek, A., & White, P. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)30030-4 · Cited by 405
Research works printed but not linked: 2
- Sutherland, D. J., Ruse, J. L. & Laidlaw, J. C. Can. med. Assoc. J. 95, 1109–1119 (1966).
- Pickering, G. W. in The Epidemiology of Hypertension (eds Stamler, J., Stamler, R. & Pullman, T. N.) 18–27 (Grune & Stratton, New York, 1967).
Cited by
Items 301–400 of 995
Kikuya, M., Sugimoto, K., Katsuya, T., SUZUKI, M., Sato, T., Funahashi, J., Katoh, R., Kazama, I., Michimata, M., Araki, T., et al. (2003) · Hypertension Research · doi:10.1291/hypres.26.141 · Cited by 50
A diagnostic approach for the child with hypertension
Varda, N. M., & Gregorič, A. (2005) · Pediatric Nephrology · doi:10.1007/s00467-004-1737-0 · Cited by 50
Serum 18-Hydroxycortisol in Primary Aldosteronism, Hypertension, and Normotensives
Mosso, L., Gómez-Sánchez, C. E., Foecking, M. F., & Fardella, C. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.688 · Cited by 50
When is cortisol a mineralocorticoid?
Clore, J. N., Schoolwerth, A. C., & Watlington, C. O. (1992) · Kidney International · doi:10.1038/ki.1992.421 · Cited by 54
Matsubara, M., Kikuya, M., Ohkubo, T., Metoki, H., Omori, F., Fujiwara, T., Suzuki, M., Michimata, M., Hozawa, A., Katsuya, T., et al. (2001) · Journal of Hypertension · doi:10.1097/00004872-200112000-00010 · Cited by 50
Salt and Blood Pressure: New Insight from Human Genetic Studies
LIFTON, R. P., WILSON, F. H., CHOATE, K. A., & GELLER, D. S. (2002) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2002.67.445 · Cited by 52
Self-citationUnderstanding primary aldosteronism: impact of next generation sequencing and expression profiling
Monticone, S., Else, T., Mulatero, P., Williams, T. A., & Rainey, W. E. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.015 · Cited by 51
Genetic mechanisms of human hypertension and their implications for blood pressure physiology
Seidel, E., & Scholl, U. I. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00032.2017 · Cited by 60
Renal tubular transport and the genetic basis of hypertensive disease
Lang, F. J. W., Capasso, G., Schwab, M. G., & Waldegger, S. (2005) · Clinical and Experimental Nephrology · doi:10.1007/s10157-005-0355-x · Cited by 54
MacConnachie, A., Kelly, K. F., McNamara, A., Loughlin, S., Gates, L. J., Inglis, G., Jamieson, A., Connell, J., & Haites, N. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.12.4328 · Cited by 50
Quinkler, M., Oelkers, W., & Diederich, S. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440087 · Cited by 49
Molecular genetics of salt-sensitivity and hypertension.
Luft, F. C. (2001) · PubMed · Cited by 53
Present status of genetic mechanisms in hypertension
Luft, F. C. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00118-4 · Cited by 54
Gene Targeting Approaches to Analyzing Hypertension
TAKAHASHI, N., & SMITHIES, O. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1071598 · Cited by 49
Naito, T., Inoue, K., Sonehara, K., Baba, R., Kodama, T., Otagaki, Y., Okada, A., Itcho, K., Kobuke, K., Kishimoto, S., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.062349 · Cited by 54
Palmer, E. E., Speirs, H. J. L., Taylor, P. J., Mullan, G. L., Turner, G., Einfeld, S., Tonge, B. J., & Mowat, D. R. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36279 · Cited by 49
EJE Prize 2013: Regulation of aldosterone secretion: from physiology to disease
Beuschlein, F. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0263 · Cited by 53
Disordered CYP11B2 Expression in Primary Aldosteronism
Gómez-Sánchez, C. E., Kuppusamy, M., Reincke, M., & Williams, T. A. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-122238 · Cited by 49
Novel applications of array comparative genomic hybridization in molecular diagnostics
Cheung, S. W., & Bi, W. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1479253 · Cited by 58
Chance, P. F., & Pleasure, D. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540110060006 · Cited by 47
Disorders of Potassium Balance
Mount, D. B., & Zandi‐Nejad, K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10017-x · Cited by 50
Pathogenesis of salt sensitivity of blood pressure
Weinberger, M. H. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0014-y · Cited by 47
Genetic Analysis in Human Hypertension.
Kato, N. (2002) · Hypertension Research · doi:10.1291/hypres.25.319 · Cited by 54
Jeske, Y. W. A., So, A., Kelemen, L., Sukor, N., Willys, C., Bulmer, B., Gordon, R. D., Duffy, D. L., & Stowasser, M. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04882.x · Cited by 47
Molecular mechanism of transcriptional activation of angiotensinogen gene by proximal promoter.
Tamura, K., Umemura, S., Ishii, M., Tanimoto, K., Murakami, K., & Fukamizu, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117113 · Cited by 48
The role of 11β-hydroxysteroid dehydrogenase in the pathogenesis of hypertension
Uum, S. H. M. V., Hermus, A. R., Smits, P., Thien, T., & Lenders, J. W. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00299-x · Cited by 60
Primary Aldosteronism: Mutations, Mechanisms, Prevalence, and Public Health
Funder, J. W. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12935 · Cited by 50
Chang, H., Chu, T., Huang, H., Chueh, S., Wu, V., Chen, Y., Hsieh, B., & Wu, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2338 · Cited by 46
Low renin hypertensive states: perspectives, unsolved problems, future research
Gordon, R. D., Laragh, J. H., & Funder, J. W. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.02.004 · Cited by 49
Fardella, C., Pinto, M. P., Mosso, L. M., Gómez-Sánchez, C. E., Jalil, J., & Montero, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7920 · Cited by 46
Portrat, S., Mulatero, P., Curnow, K. M., Chaussain, J.-L., Morel, Y., & Pascoe, L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7671 · Cited by 46
Maternal component in the familial aggregation of hypertension
DeStefano, A. L., Gavras, H., Heard‐Costa, N. L., Bursztyn, M., Manolis, A. J., Farrer, L. A., Baldwin, C. T., Gavras, I., & Schwartz, F. (2001) · Clinical Genetics · doi:10.1034/j.1399-0004.2001.600103.x · Cited by 46
Differential diagnosis of primary aldosteronism subtypes
Mulatero, P., Bertello, C., Verhovez, A., Rossato, D., Giraudo, G., Mengozzi, G., Limerutti, G., Avenatti, E., Tizzani, D., & Veglio, F. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0038-1 · Cited by 47
Pravenec, M., & Kurtz, T. W. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.086900 · Cited by 52
Connell, J., Fraser, R., MacKenzie, S. M., Friel, E. C., Ingram, M. C., Holloway, C. D., & Davies, E. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.025 · Cited by 45
Basson, J., Simino, J. M., & Rao, D. C. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0241-8 · Cited by 53
Litchfield, W. R., Coolidge, C., Silva, P., Lifton, R. P., Fallo, F., Williams, G. H., & Dluhy, R. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3964 · Cited by 53
Self-citationStowasser, M., Huggard, P. R., Rossetti, T. R., Bachmann, A. W., & Gordon, R. D. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6159 · Cited by 49
Role of environmental toxicants in the development of hypertensive and cardiovascular diseases
Habeeb, E. A., Aldosari, S. A., Saghir, S. A., Cheema, M., Momenah, T., Husain, K. M., Omidi, Y., Rizvi, S. A. A., Akram, M., & Ansari, R. A. (2022) · Toxicology Reports · doi:10.1016/j.toxrep.2022.03.019 · Cited by 54
Genomics of Blood Pressure and Hypertension: Extending the Mosaic Theory Toward Stratification
Lip, S. Z. L., & Padmanabhan, S. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.03.001 · Cited by 45
Genetic and Genomic Mechanisms of Primary Aldosteronism
Fernandes-Rosa, F. L., Boulkroun, S., & Zennaro, M. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.05.005 · Cited by 62
Genetics of Hypertension: Therapeutic Implications
O???Byrne, S., & Caulfield, M. J. (1998) · Drugs · doi:10.2165/00003495-199856020-00004 · Cited by 47
Mouse Chromosome Engineering for Modeling Human Disease
van der Weyden, L., & Bradley, A. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115741 · Cited by 47
Genetic Diseases of Steroid Metabolism
(1994) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)61147-4 · Cited by 43
Molecular Mechanisms for CMT1A Duplication and HNPP Deletion
Boerkoel, C. F., Inoue, K., Reiter, L. T., Warner, L. E., & Lupski, J. R. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08563.x · Cited by 42
Ionizing radiation and genetic risks
Sankaranarayanan, K., Chakraborty, R., & Boerwinkle, E. (1999) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(98)00017-9 · Cited by 48
Effects of Chronic ACTH Excess on Human Adrenal Cortex
BERTAGNA, X. Y. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00043 · Cited by 43
Kong, H., Qian, Y., Tang, X., Zhang, J., Gao, P., Zhang, Y., & Zhu, D. (2012) · Hypertension Research · doi:10.1038/hr.2012.89 · Cited by 48
Adachi, M., Muroya, K., Asakura, Y., Sugiyama, K., Homma, K., & Hasegawa, T. (2014) · Hormone Research in Paediatrics · doi:10.1159/000358197 · Cited by 43
Scholl, U. I., & Lifton, R. P. (2013) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e32835cecf8 · Cited by 42
Self-citationGenetics of arterial hypertension and hypotension
Rosskopf, D., Schürks, M., Rimmbach, C., & Schäfers, R. F. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0133-2 · Cited by 49
Inherited forms of mineralocorticoid hypertension
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.04.010 · Cited by 45
Secondary hypertension: Evaluation and treatment
Akpunonu, B. E., Mulrow, P. J., & Hoffman, E. A. (1996) · Disease-a-Month · doi:10.1016/s0011-5029(96)90019-x · Cited by 55
Davies, E., Holloway, C. D., Ingram, M. C., Friel, E. C., Inglis, G. C., Swan, L., Hillis, W. S., Fraser, R., & Connell, J. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01264.x · Cited by 43
Litchfield, W. R., & Dluhy, R. G. (1995) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30033-1 · Cited by 47
Self-citationCorvol, P. L., Jeunemaître, X., Charru, A., & Soubrier, F. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90267-3 · Cited by 41
Miyahara, K., Kawamoto, T., Mitsuuchi, Y., Toda, K., Imura, H., Gordon, R. D., & Shizuta, Y. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92286-7 · Cited by 39
Old and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism
Prada, E. T. A., Burrello, J., Reincke, M., & Williams, T. A. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10111 · Cited by 39
P450 Enzymes in Steroid Processing
Auchus, R. J., & Miller, W. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_12 · Cited by 44
Sugimoto, K., Akasaka, H., Katsuya, T., Node, K., Fujisawa, T., Shimaoka, I., Yasuda, O., Ohishi, M., Ogihara, T., Shimamoto, K., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114082 · Cited by 39
Primary aldosteronism: Rare bird or common cause of secondary hypertension?
Stowasser, M. (2001) · Current Hypertension Reports · doi:10.1007/s11906-001-0045-3 · Cited by 41
Saga of Familial Hyperaldosteronism: Yet a New Channel
Lenzini, L., Prisco, S., Caroccia, B., & Rossi, G. P. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11150 · Cited by 41
Renin-Independent hypermineralocorticoidism
Young, W. F., & Hogan, M. J. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(94)90090-6 · Cited by 39
Salt-sensitive hypertension: Lessons from animal models
Sanders, P. W. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90265-6 · Cited by 44
Carvajal, C. A., Romero, D. N. G., Mosso, L. M., lez, A. G., Campino, C., Montero, J., & Fardella, C. (2005) · Journal of Hypertension · doi:10.1097/00004872-200501000-00015 · Cited by 40
Genetics of Human Hypertension
Ruppert, V., & Maisch, B. (2003) · Herz · doi:10.1007/s00059-003-2516-6 · Cited by 46
Steroid 11β-Hydroxylase Deficiency and Related Disorders
White, P. C., & Speiser, P. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30100-2 · Cited by 45
Mutations in CYP11B1 gene: Phenotype–genotype correlations
Zhu, Y., Cordero, J. J., Can, S., Cai, L., You, X., Herrera, C., DeFillo‐Ricart, M., Shackleton, C., & Imperato‐McGinley, J. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20108 · Cited by 37
Genetics of Hypertensive Syndrome
Martínez‐Aguayo, A., & Fardella, C. (2009) · Hormone Research in Paediatrics · doi:10.1159/000208798 · Cited by 47
Aldosterone signaling modifies capillary formation by human bone marrow endothelial cells
Chen, W., Valamanesh, F., Mirshahi, T., Soria, J., Tang, R., Agarwal, M. K., & Mirshahi, M. (2004) · Vascular Pharmacology · doi:10.1016/j.vph.2003.08.003 · Cited by 37
Finding genes that cause human hypertension
Lifton, R. P., & Jeunemaı̂tre, X. (1996) · Springer eBooks · doi:10.1007/978-94-009-0083-7_13 · Cited by 37
Self-citationTubular Disorders of Electrolyte Regulation
Devuyst, O., Konrad, M., Jeunemaître, X., & Zennaro, M. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_38 · Cited by 36
Inherited forms of mineralocorticoid hypertension
Hassan-Smith, Z., & Stewart, P. M. (2011) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283469444 · Cited by 36
Metabolomics reveals new metabolic perturbations in children with type 1 diabetes: GALDERISIet al.
Galderisi, A., Pirillo, P., Moret, V., Stocchero, M., Gucciardi, A., Perilongo, G., Moretti, C., Monciotti, C., Giordano, G., & Baraldi, E. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12524 · Cited by 36
Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome
Vaduva, P., Bonnet-Serrano, F., & Bertherat, J. Y. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa075 · Cited by 40
Seidel, E., Schewe, J., Zhang, J., Dinh, H. A., Forslund, S. K., Markó, L., Hellmig, N., Peters, J., Müller, D. N., Lifton, R. P., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014876118 · Cited by 40
Self-citationPolymorphisms in CYP11B Genes and 11-Hydroxylase Activity
White, P. C., & Rainey, W. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2452 · Cited by 41
Genetics of hypertension: discoveries from the bench to human populations
Franceschini, N., & Le, T. H. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00334.2013 · Cited by 40
Genetic Determination of Human Essential Hypertension
Matsubara, M. (2000) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.192.19 · Cited by 38
Stowasser, M., Gartside, M. G., & Gordon, R. D. (1997) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1997.tb00999.x · Cited by 36
Mulatero, P., Scholl, U. I., Fardella, C., Charmandari, E., Januszewicz, A., Reincke, M., Gómez-Sánchez, C. E., Stowasser, M., & Dekkers, O. M. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae041 · Cited by 45
Genetic determinants of hypertension: An update
Harrison, M., Maresso, K. C., & Broeckel, U. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0091-1 · Cited by 36
Molecular Genetic and Genomic Alterations in Cushing’s Syndrome and Primary Aldosteronism
Kamilaris, C. D. C., Stratakis, C. A., & Hannah‐Shmouni, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.632543 · Cited by 46
Familial Varieties Of Primary Aldosteronism
Stowasser, M., Gunasekera, T. G., & Gordon, R. D. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03574.x · Cited by 35
The potential of targeting CYP11B
Bernhardt, R. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1151873 · Cited by 35
Monogenic forms of human hypertension
Toka, H. R., & Luft, F. C. (2002) · Seminars in Nephrology · doi:10.1053/snep.2002.30206 · Cited by 35
Advances in genetic hypertension
Williams, S. S. (2007) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32801e217c · Cited by 35
Jackson, S. N., Williams, B., Houtman, P., & Trembath, R. C. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.6.510 · Cited by 36
Aldosterone-producing adenoma without hypertension: a report of two cases
Vantyghem, M., Ronci, N., Provost, F., Ghulam, A., Lefèbvre, J., Jeunemaı̂tre, X., & Tabarin, A. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410279 · Cited by 35
Molecular basis of human hypertension: The role of angiotensin
Peters, J. (1995) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80672-5 · Cited by 38
Genetics in endocrinology: Genetics of mineralocorticoid excess: an update for clinicians
Zennaro, M., Rickard, A. J., & Boulkroun, S. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0813 · Cited by 38
Genetics of primary hyperaldosteronism
Dutta, R. K., Söderkvist, P., & Gimm, O. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0055 · Cited by 38
Genetics of primary aldosteronism
Mulatero, P., Morello, F., & Veglio, F. (2004) · Journal of Hypertension · doi:10.1097/00004872-200404000-00001 · Cited by 36
Pseudohyperaldosteronism: Pathogenetic Mechanisms
Armanini, D., Calò, L. A., & Semplicini, A. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609355 · Cited by 37
Wu, A., Wolley, M. J., & Stowasser, M. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0170-6 · Cited by 36
Torpy, D. J., Stratakis, C. A., & Chrousos, G. P. (1997) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60644-5 · Cited by 37
Vallotton, M. B. (1996) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1996.tb02060.x · Cited by 34
The Genetics of Primary Aldosteronism
Funder, J. W. (2011) · Science · doi:10.1126/science.1202887 · Cited by 37
Gómez-Sánchez, C. E., & Oki, K. (2013) · Endocrinology · doi:10.1210/en.2013-1733 · Cited by 37
The Kidneys and Aldosterone/Mineralocorticoid Receptor System in Salt-Sensitive Hypertension
Shibata, S., & Fujita, T. (2011) · Current Hypertension Reports · doi:10.1007/s11906-010-0175-6 · Cited by 38
Metadata
- Authors
- Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M.
- Affiliations
- Howard Hughes Medical Institute (US)
- Brigham and Women's Hospital (US)
- Veterans Health Administration (US)
- ORCID
- Lifton, Richard P.
- Venue
- Nature
- Published
- 1992-01
- Volume
- 355
- Issue
- 6357
- Pages
- 262-265
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1979069430
- Semantic Scholar
- 48f7453ea9e77a6f893ab90603be6343f5cad138
- Cited by
- 1,158
- References
- 23
- Citations by year
- 2026: 18 · 2025: 10 · 2024: 21 · 2023: 37 · 2022: 29 · 2021: 26 · 2020: 25 · 2019: 24 · 2018: 36 · 2017: 35 · 2016: 30 · 2015: 34 · 2014: 34 · 2013: 36 · 2012: 32
- FWCI
- 30.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- glucocorticoid-remediable aldosteronism, aldosterone synthase, 11β-hydroxylase, fusion genes, gene duplication, unequal crossover, hypertension, hyperaldosteronism, 18-oxocortisol, 18-hydroxycortisol, ACTH, chromosome 8q, genetic linkage, autosomal dominant disorder, adrenal glomerulosa
- MeSH terms
- Base Sequence, Chimera, Crossing Over, Genetic, Cytochrome P-450 Enzyme System, Exons, Female, Humans, Hyperaldosteronism, Hypertension, Introns, Male, Molecular Sequence Data, Oligodeoxyribonucleotides, Pedigree, Steroid Hydroxylases, Steroid 11-beta-Hydroxylase, Polymerase Chain Reaction, Cytochrome P-450 CYP11B2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.